Pharmacogenetics—the future is networks K Walsh, BMJ, March 7, 2019

Main|Search|PHGKB




Last Posted: Mar 08, 2019

---

• Pharmacogenetics—the future is networks
  K Walsh, BMJ, March 7, 2019
• Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment.
  Pavlovic Sonja et al. Genes 2019 Mar 10(3)
• Early Lessons from the Implementation of Genomic Medicine Programs.
  Williams Marc S et al. Annual review of genomics and human genetics 2019 Feb
• CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.
  Damkier Per et al. Scientific reports 2017 7(1) 7727
• Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis.
  Xiao Wenjing et al. Pharmacogenomics 2018 19(5) 383-392
• The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.
  Allyn-Feuer Ari et al. Pharmacogenomics 2018 19(5) 413-434
• What is pharmacogenomics?
  Genetics Home Reference, 2019
• Precision dosing of warfarin: open questions and strategies.
  Li Xi et al. The pharmacogenomics journal 2019 Feb
• Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.
  Naidoo Anushka et al. Pharmacogenomics 2019 Feb
• Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants.
  Tseng Andrew S et al. Cardiovascular drugs and therapy 2018 32(1) 121-126

more